![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 60.50 | 60.00 | 61.00 | 60.50 | 60.50 | 60.50 | 14,770 | 07:44:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -2.77 | 8.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/12/2019 16:27 | I have been having a good scout around looking where to invest my Xmas bonus. Can't find a rising chart anywhere. | ![]() ducatiman | |
06/12/2019 15:03 | Surprised .9 has held. Somebody must want them. | ![]() ducatiman | |
06/12/2019 12:46 | The pilot study is due to start this month and then it's a 3 month wait for the trial to end. Hope there are other trials in the pipeline while the 1st one is running otherwise it's going to be a long wait for any share price upturn. | ![]() digger2779 | |
05/12/2019 23:12 | AI Reveals New Breast Cancer Patterns each Linked to Different Treatment AI algorithms that revealed five new breast cancer types that require personalized treatment, especially picking out those likely to benefit from immunotherapy. However, all other indications showed such treatments would not work for such patients. | ![]() lr2 | |
05/12/2019 17:23 | Very. No news on this trial yet then? | phillkay | |
05/12/2019 12:43 | Sammy get lost if you have nothing constructive to say | sonie01 | |
04/12/2019 19:03 | Apologies dc it is frustrating | sonie01 | |
04/12/2019 17:50 | Language sonie!! Lol. Frustrating isn't it? | ![]() ducatiman | |
04/12/2019 17:47 | Good posts Ged, LR2. A "sleeping giant"? | ![]() ducatiman | |
04/12/2019 15:43 | Well shares are bloody irritating aren't they. Going up and down over and over gain and then flatlining when you think they might get interesting ;-) | ![]() yump | |
04/12/2019 15:13 | Haha sorry! I remember counting the days ? | ![]() czc9 | |
04/12/2019 14:23 | Breast Cancer trials - TexRAD tech - South Korea - excellent results. Better than nothing eh? | ![]() lr2 | |
04/12/2019 14:14 | Thanks for that. I was just trying to bring back a little bit of optimism. Now totally deflated. ;) | ![]() ged5 | |
04/12/2019 14:11 | Long term feedbackers will remember a CE Mark for Texrad being delayed by 9 months or so previously. | ![]() czc9 | |
04/12/2019 13:43 | From the July RNS:- "By incorporating a dedicated, encrypted messaging function to Feedback's existing Cadran technology, the Directors believe it can become the only medical communication device on the market capable of sharing clinical grade medical imaging directly from a hospital PACS to mobile devices, ensuring the safe handling of patient data and facilitating a secure means of communication for clinicians across the UK. The Directors believe this new product will also be the only communication tool to be a CE marked medical device." Better get on with securing Bleepa as a CE marked device. Three months to have got this done. | ![]() ged5 | |
04/12/2019 13:21 | We can't be too far off an announcement for Bleepa being CE marked. I've read that on average it takes 6-8 weeks. If that's true it should be any time now. Some background reading:- | ![]() ged5 | |
02/12/2019 20:58 | If they got commercial deals in and outside 1.7p would be peanuts ducat. | ![]() czc9 | |
02/12/2019 19:53 | .7 very likely | ![]() sammyshares | |
02/12/2019 17:55 | Unit then they announce the CE Mark and a definite date along with other trials and possible contracts both within and outside the NHS. You could see it hit 1.7 again in short order. Of course 0.7 could come first. | ![]() ducatiman | |
02/12/2019 17:21 | Not sure who sammyshares is but the word 'expected' to start in the trial RNS isn't good news at all. If the trial doesn't start in December that's a further delay until any meaningful potential revenues for FDBK. You could see it hit the 0.7s again imho. Good luck all. | ![]() czc9 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions